Targeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based Immunotherapy

Cho, SF; Anderson, KC; Tai, YT

Tai, YT (reprint author), Dana Farber Canc Inst, LeBow Inst Myeloma Therapeut, Boston, MA 02115 USA.; Tai, YT (reprint author), Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr, Boston, MA 02115 USA.; Tai, YT (reprint author), Harvard Med Sch, Bo

FRONTIERS IN IMMUNOLOGY, 2018; 9 ():

Abstract

The approval of the first two monoclonal antibodies targeting CD38 (daratumumab) and SLAMF7 (elotuzumab) in late 2015 for treating relapsed and refrac......

Full Text Link